Fig. 6. Susceptibility of RSV B strains with and without prevalent nirsevimab binding site substitutions I206M + Q209R.
F, fusion protein; IC50 half-maximal inhibitory concentration, LOD limit of detection, RSV respiratory syncytial virus.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.